Stock M12 M1 KLINIKEN AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings M1 Kliniken AG

Equities

M12

DE000A0STSQ8

Real-time Estimate Tradegate
Other stock markets
 12:56:28 30/04/2024 pm IST 		5-day change 1st Jan Change
13.6 EUR -0.37% Intraday chart for M1 Kliniken AG +2.24% +22.32%
05/02 M1 Kliniken Mull Uplisting to Frankfurt Bourse's Prime Standard; Co-CEOs Buy 1.5 Million Shares MT
2023 M1 Kliniken Takes Ownership of Dutch Online Pharmacy MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company sustains low margins.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.13 times its estimated earnings per share for the ongoing year.
  • The valuation of the company is particularly high given the cash flows generated by its activity.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
M1 KLINIKEN AG Stock M1 Kliniken AG
+22.32% 268M -
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-17.07% 16.85B
B+
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+3.60% 12.34B
B
IHH HEALTHCARE Stock IHH Healthcare
+5.64% 11.77B
B+
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+5.01% 10.28B
B+
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+25.36% 8.38B
B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-0.68% 7.88B
A-
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+22.18% 7.29B
D
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+5.77% 6.75B
B-
GLOBAL HEALTH LIMITED Stock Global Health Limited
+52.00% 4.69B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. M12 Stock
  4. Ratings M1 Kliniken AG